What is SpartanNash Company's earnings per share (EPS)?

SpartanNash Company (SPTN) reported diluted earnings per share of $0.01 for fiscal year 2024. This represents a -99.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SpartanNash Company (SPTN) Financials

SPTN NASDAQ

Trailing 12 months to July 12, 2025

Revenue $9.7B +1.5% YoY

Net Income -$15.9M -134.6% YoY

EPS (Diluted) -$0.46 -134.6% YoY

Free Cash Flow $69.8M +54.6% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jul 12, 2025 Reported Aug 14, 2025 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2025, filed Aug 14, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SPTN SEC filings page.

SpartanNash Company (SPTN) reported $9.7B in revenue over the twelve months to Jul 12, 2025, up 1.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SPTN FY2024 2026-10-22

Gross profit held up, but rising overhead, interest, and leverage left SpartanNash with almost no reported earnings in FY2024.

In FY2024, gross profit rose to $1.51B while operating income fell to $54M, so the earnings squeeze occurred below product costs rather than in gross economics. Operating cash flow reached $206M against net income of only $299K, a mismatch that points to working-capital or non-cash contributions rather than recurring profitability.

The business remains a thin-margin operator: FY2024 gross margin reached 15.8%, yet operating margin was only 0.6%, leaving little room for overhead or financing costs to move. Revenue fell 1.8%, but gross profit rose 1.8%; this suggests the pressure was not primarily weaker merchandise economics. SG&A still increased 1.1%, reinforcing that interpretation.

Cash conversion improved from negative free cash flow of $31M in FY2023 to positive $73M in FY2024, despite the near-zero accounting profit. The balance sheet simultaneously became more finance-dependent: liabilities rose 17.8% while assets rose 10.5%, lifting liabilities to 71.4% of assets from 67.0%.

Financial Health Signals

Financial Health Score 37/100

Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SpartanNash Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

SpartanNash Company has an operating margin of 0.6%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 43/100, indicating healthy but not exceptional operating efficiency. This is down from 1.1% the prior year.

Growth

SpartanNash Company's revenue declined 1.8% year-over-year, from $9.7B to $9.5B. This contraction results in a growth score of 29/100.

Leverage

Liquidity

SpartanNash Company's current ratio of 1.57 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

SpartanNash Company's free cash flow margin of 0.8% results in a low score of 27/100. Capital expenditures of $132.4M absorb a large share of operating cash flow.

Returns

SpartanNash Company's ROE of 0.0% shows moderate profitability relative to equity, earning a score of 51/100. This is down from 6.7% the prior year.

Piotroski F-Score Partial

5/8

SpartanNash Company passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed

N/A

SpartanNash Company reported $299K of net income while generating $205.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Interest Coverage At Risk

1.20x

SpartanNash Company earns $1.20 in operating income for every $1 of interest expense ($54.0M vs $44.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.3B

YoY+1.8%

QoQ-21.9%

5Y CAGR+0.8%

10Y CAGR+2.4%

SpartanNash Company generated $2.3B in revenue in Q2 2025. This represents an increase of 1.8% from the same quarter a year earlier. Against the prior quarter it is down 21.9%.

EBITDA

$46.0M

YoY-7.0%

QoQ-17.6%

SpartanNash Company's EBITDA was $46.0M in Q2 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.0% from the same quarter a year earlier. Against the prior quarter it is down 17.6%.

Net Income

$6.2M

YoY-46.1%

QoQ+197.6%

5Y CAGR-26.3%

10Y CAGR-11.2%

SpartanNash Company reported $6.2M in net income in Q2 2025. This represents a decrease of 46.1% from the same quarter a year earlier. Against the prior quarter it is up 197.6%.

EPS (Diluted)

$0.18

YoY-47.1%

QoQ+200.0%

5Y CAGR-25.8%

10Y CAGR-10.4%

SpartanNash Company earned $0.18 per diluted share (EPS) in Q2 2025. This represents a decrease of 47.1% from the same quarter a year earlier. Against the prior quarter it is up 200.0%.

Cash & Balance Sheet

Free Cash Flow

$67.1M

YoY-2.3%

QoQn/m

5Y CAGR+3.6%

10Y CAGR+3.0%

SpartanNash Company generated $67.1M in free cash flow in Q2 2025, representing cash available after capex. This represents a decrease of 2.3% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$25.5M

YoY+1.0%

QoQ+27.7%

5Y CAGR-5.9%

10Y CAGR+6.9%

SpartanNash Company held $25.5M in cash as of Q2 2025; no long-term debt figure is on record for that period.

Dividends Per Share

$0.22

YoY+1.1%

QoQ0.0%

SpartanNash Company paid $0.22 per share in dividends in Q2 2025. This represents an increase of 1.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

34M

YoY+0.3%

QoQ0.0%

5Y CAGR-1.1%

10Y CAGR-1.0%

SpartanNash Company had 34M shares outstanding in Q2 2025. This represents an increase of 0.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin

16.9%

YoY+1.0pp

QoQ+0.3pp

5Y change+1.4pp

10Y change+2.3pp

SpartanNash Company's gross margin was 16.9% in Q2 2025, indicating the percentage of revenue retained after direct costs. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin

0.8%

YoY-0.4pp

QoQ+0.2pp

SpartanNash Company's operating margin was 0.8% in Q2 2025, reflecting core business profitability. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Net Margin

0.3%

YoY-0.2pp

QoQ+0.2pp

5Y change-1.0pp

10Y change-0.9pp

SpartanNash Company's net profit margin was 0.3% in Q2 2025, showing the share of revenue converted to profit. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Return on Equity

0.8%

YoY-0.7pp

QoQ+0.5pp

5Y change-3.2pp

10Y change-1.8pp

SpartanNash Company's quarterly ROE was 0.8% in Q2 2025: one quarter's net income over shareholder equity, not annualized. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Capital Allocation

Share Buybacks

YoY-100.0%

QoQn/m

SpartanNash Company repurchased no shares in Q2 2025. This represents a decrease of 100.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Capital Expenditures

$19.6M

YoY-27.2%

QoQ-38.0%

5Y CAGR+9.0%

10Y CAGR-2.2%

SpartanNash Company invested $19.6M in capex in Q2 2025, funding long-term assets and infrastructure. This represents a decrease of 27.2% from the same quarter a year earlier. Against the prior quarter it is down 38.0%.

R&D Spending

Not reported for Q2 2025.

SPTN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPTN quarterly income statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$9.7B	$9.5B-1.8%	$9.7B+0.9%	$9.6B+8.0%	$8.9B-4.5%	$9.3B+9.5%	$8.5B+5.8%	$8.1B+1.3%	$8.0B+5.3%	$7.6B-1.2%	$7.7B-3.3%	$7.9B+203.5%	$2.6B-1.0%	$2.6B+4.0%	$2.5B-0.7%	$2.6B
Cost of Revenue	$8.1B	$8.0B-2.5%	$8.2B+1.2%	$8.1B+8.2%	$7.5B-5.0%	$7.9B+8.7%	$7.3B+4.9%	$7.0B+2.0%	$6.8B+5.7%	$6.4B-1.3%	$6.5B-3.3%	$6.8B+227.7%	$2.1B-0.7%	$2.1B+5.1%	$2.0B-0.8%	$2.0B
Gross Profit	$1.6B	$1.5B+1.8%	$1.5B-0.8%	$1.5B+6.7%	$1.4B-1.5%	$1.4B+14.6%	$1.2B+12.0%	$1.1B-3.0%	$1.1B+3.0%	$1.1B-0.4%	$1.1B-3.5%	$1.2B+111.9%	$545.5M-1.9%	$556.1M-0.1%	$556.5M-0.4%	$558.6M
SG&A Expenses	$1.5B	$1.4B+1.1%	$1.4B-4.3%	$1.4B+9.0%	$1.3B+0.9%	$1.3B+10.7%	$1.2B+17.5%	$997.4M-1.7%	$1.0B+5.4%	$963.2M-1.3%	$975.6M-4.6%	$1.0B+111.7%	$483.0M-1.4%	$489.6M+0.3%	$488.0M-1.2%	$493.8M
Operating Income	$34.3M	$54.0M-49.4%	$106.7M+55.7%	$68.5M-38.9%	$112.2M+9.6%	$102.4M+79.8%	$56.9M-19.2%	$70.5Mn/m	-$106.7M-197.7%	$109.2M-11.1%	$122.9M+7.0%	$114.8M+88.4%	$61.0M-8.3%	$66.5M-2.2%	$68.0M+15.9%	$58.7M
EBITDA	N/A	$157.4M-23.4%	$205.4M+26.2%	$162.7M-20.6%	$204.9M+6.6%	$192.3M+32.3%	$145.3M-5.2%	$153.4Mn/m	-$22.3M-111.8%	$188.4M-9.3%	$207.8M+2.2%	$203.3M+103.7%	$99.8M-3.3%	$103.3M0.0%	$103.2M+10.3%	$93.6M
Interest Expense	$48.3M	$44.8M+12.4%	$39.9M+75.0%	$22.8M+64.5%	$13.9M-24.8%	$18.4M-46.7%	$34.5M+13.3%	$30.5M+20.3%	$25.3M+32.8%	$19.1M-12.5%	$21.8M-10.6%	$24.4M+82.1%	$13.4M-10.8%	$15.0M-0.4%	$15.1M-7.9%	$16.4M
Income Tax	$2.7M	$10.7M-40.0%	$17.9M+44.3%	$12.4M-50.2%	$24.9M+163.6%	$9.4Mn/m	-$2.3M-133.9%	$6.9Mn/m	-$79.0M-340.2%	$32.9M-11.3%	$37.1M+18.4%	$31.3M+103.1%	$15.4M-21.6%	$19.7M-3.6%	$20.4M+23.9%	$16.5M
Net Income	-$15.9M	$299K-99.4%	$52.2M+51.3%	$34.5M-53.2%	$73.8M-2.8%	$75.9M+1222.1%	$5.7M-82.9%	$33.6Mn/m	-$52.8M-193.0%	$56.8M-9.4%	$62.7M+7.0%	$58.6M+113.8%	$27.4M-13.7%	$31.8M-1.7%	$32.3M+26.4%	$25.6M
EPS (Basic)	N/A	$0.01-99.3%	$1.53+56.1%	$0.98-52.7%	$2.07-2.4%	$2.12+1225.0%	$0.16-82.8%	$0.93n/m	-$1.41-192.8%	$1.52-9.0%	$1.67+7.1%	$1.56	$1.26-9.4%	$1.39-2.8%	$1.43+25.4%	$1.14
EPS (Diluted)	-$0.46	$0.01-99.3%	$1.50+57.9%	$0.95-53.7%	$2.05-3.3%	$2.12+1225.0%	$0.16-82.8%	$0.93n/m	-$1.41-193.4%	$1.51-9.0%	$1.66+7.1%	$1.55	$1.25-10.1%	$1.39-2.1%	$1.42+24.6%	$1.14
Diluted Shares (Avg)	N/A	34M-2.0%	35M-3.9%	36M+1.0%	36M+0.2%	36M+1.4%	35M+0.4%	35M-4.2%	37M-0.3%	37M-0.5%	37M0.0%	37M	21M-4.6%	22M-1.7%	23M+0.9%	22M

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Revenue	$2.3B+1.8%	$2.9B+3.7%	$2.3B+0.7%	$2.3B-0.6%	$2.2B-3.5%	$2.8B-3.5%	$2.2B-2.8%	$2.3B-1.4%
Cost of Revenue	$1.9B+0.6%	$2.4B+2.6%	$1.9B-0.5%	$1.9B-1.1%	$1.9B-4.2%	$2.4B-3.9%	$1.9B-3.1%	$1.9B-1.5%
Gross Profit	$382.6M+8.4%	$481.5M+9.3%	$364.5M+7.5%	$354.6M+2.0%	$353.0M+0.2%	$440.3M-1.4%	$339.0M-0.7%	$347.5M-1.0%
SG&A Expenses	$355.3M+11.7%	$459.1M+13.7%	$335.5M+9.5%	$324.1M+0.4%	$318.2M-0.2%	$403.6M-3.5%	$306.5M-8.1%	$322.8M-3.2%
Operating Income	$18.1M-30.6%	$19.0M-38.1%	-$27.7M-217.7%	$24.9M+8.0%	$26.1M-27.0%	$30.6M+25.9%	$23.5M+168.6%	$23.1M+19.5%
EBITDA	$46.0M-7.0%	$55.8M-8.9%	-$2.4M-105.2%	$49.1M+6.4%	$49.5M-15.1%	$61.3M+13.3%	$46.9M+53.0%	$46.1M+12.1%
Interest Expense	$12.3M+16.5%	$15.2M+12.8%	$10.9M+12.6%	$9.9M+6.8%	$10.5M+12.8%	$13.5M+16.4%	$9.7M+20.5%	$9.3M+53.4%
Income Tax	-$138K-103.0%	$1.9M-63.1%	-$3.4M-178.6%	$4.3M+24.6%	$4.6M-39.3%	$5.2M+114.6%	$4.4M+402.7%	$3.5M-24.2%
Net Income	$6.2M-46.1%	$2.1M-84.0%	-$35.1M-440.4%	$10.9M-1.9%	$11.5M-41.0%	$13.0M+14.4%	$10.3M+1485.4%	$11.1M+17.6%
EPS (Basic)	$0.18-47.1%	$0.06-84.2%	-$1.04-435.5%	$0.330.0%	$0.34-40.4%	$0.38+15.2%	$0.31+1450.0%	$0.33+22.2%
EPS (Diluted)	$0.18-47.1%	$0.06-83.8%	-$1.02-440.0%	$0.320.0%	$0.34-39.3%	$0.37+15.6%	$0.30+1400.0%	$0.32+23.1%
Diluted Shares (Avg)	34M+1.4%	34M-1.5%	N/A	34M-1.2%	34M-2.0%	35M-2.4%	N/A	35M-3.5%

Not reported in any period shown, so not listed: R&D Expenses.

SPTN Balance Sheet

SPTN quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$2.6B+10.5%	$2.4B+2.1%	$2.3B+4.5%	$2.2B-3.1%	$2.3B0.0%	$2.3B+15.5%	$2.0B-4.1%	$2.1B+6.5%	$1.9B+0.7%	$1.9B-0.8%	$1.9B+144.7%	$789.7M+3.4%	$763.5M+1.6%	$751.4M	N/A
Current Assets	$1.1B+1.3%	$1.1B+1.0%	$1.1B+11.4%	$957.2M-5.7%	$1.0B+1.8%	$996.7M-0.4%	$1.0B-0.3%	$1.0B+12.4%	$893.5M+1.1%	$883.6M-3.3%	$913.4M+343.0%	$206.2M-1.7%	$209.6M-1.5%	$212.9M	N/A
Cash & Equivalents	$21.6M+20.1%	$18.0M-38.2%	$29.1M+172.7%	$10.7M-46.4%	$19.9M-17.7%	$24.2M+30.1%	$18.6M+18.6%	$15.7M-35.7%	$24.4M+7.2%	$22.7M+252.6%	$6.4M+5.7%	$6.1M-77.0%	$26.5M-39.6%	$43.8M+377.9%	$9.2M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$546.3M-5.0%	$575.2M+0.7%	$571.1M+9.3%	$522.3M-3.6%	$541.8M+0.9%	$537.2M-3.0%	$553.8M-7.3%	$597.2M+10.6%	$539.9M+3.6%	$521.2M-9.7%	$577.2M+363.0%	$124.7M+24.9%	$99.8M-3.9%	$103.8M	N/A
Accounts Receivable	$386.8M+2.0%	$379.2M+1.0%	$375.6M+14.5%	$328.1M-2.7%	$337.3M+5.1%	$321.0M+2.0%	$314.8M+0.8%	$312.2M+23.5%	$252.8M-10.4%	$282.2M+6.1%	$266.0M+423.0%	$50.9M-13.3%	$58.6M+4.1%	$56.3M	N/A
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$181.0M-0.6%	$182.2M0.0%	$182.2M+0.6%	$181.0M0.0%	$181.0M0.0%	$181.0M+1.3%	$178.6M0.0%	$178.6M-44.6%	$322.7M-0.1%	$322.9M+8.6%	$297.3M+20.4%	$246.8M+2.8%	$240.2M-0.4%	$241.2M	N/A
Total Liabilities	$1.9B+17.8%	$1.6B+2.4%	$1.5B+8.2%	$1.4B-7.7%	$1.5B-3.0%	$1.6B+26.6%	$1.3B-5.8%	$1.3B+20.7%	$1.1B-1.9%	$1.1B-4.9%	$1.2B+161.0%	$454.0M+3.2%	$439.9M-1.4%	$445.9M	N/A
Current Liabilities	$695.2M+5.4%	$659.9M-6.4%	$705.0M+7.5%	$655.8M-4.9%	$689.6M+22.0%	$565.1M+18.6%	$476.5M-3.7%	$494.6M-2.3%	$506.0M+3.8%	$487.3M+6.5%	$457.7M+137.2%	$193.0M+4.3%	$185.0M+11.7%	$165.6M	N/A
Non-Current Liabilities	$1.2B+26.8%	$917.5M+9.8%	$835.5M+8.8%	$768.1M-9.9%	$852.8M-16.6%	$1.0B+31.2%	$779.5M-7.1%	$839.3M+40.1%	$599.0M-6.3%	$639.2M-12.1%	$727.3M+178.6%	$261.0M+2.4%	$254.9M-9.0%	$280.3M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	$481.3M-29.4%	$682.2M+0.4%	$679.8M-8.2%	$740.8M+79.1%	$413.7M-11.6%	$467.8M-15.0%	$550.5M+277.4%	$145.9M+9.2%	$133.6M-21.8%	$170.7M	N/A
Total Equity	$743.5M-4.5%	$778.2M+1.6%	$766.1M-2.1%	$782.9M+6.5%	$735.0M+6.9%	$687.5M-4.0%	$715.9M-0.8%	$722.0M-12.5%	$825.4M+4.4%	$790.8M+5.8%	$747.3M+122.6%	$335.7M+3.7%	$323.6M+5.9%	$305.5M+11.5%	$273.9M
Retained Earnings	$287.4M-9.4%	$317.1M+7.5%	$295.0M+1.5%	$290.5M+18.3%	$245.5M+23.4%	$198.9M-19.7%	$247.6M+3.2%	$240.0M-23.8%	$314.9M+12.2%	$280.5M+17.8%	$238.1M+17.4%	$202.8M+11.3%	$182.3M+16.5%	$156.4M	N/A

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Total Assets	$2.6B+8.1%	$2.6B+10.2%	$2.6B+10.5%	$2.5B+5.7%	$2.4B+1.7%	$2.3B+2.0%	$2.4B+2.1%	$2.3B-0.3%
Current Assets	$1.1B+4.1%	$1.1B+3.0%	$1.1B+1.3%	$1.1B+4.8%	$1.0B-3.7%	$1.1B-0.3%	$1.1B+1.0%	$1.1B-5.1%
Cash & Equivalents	$25.5M+1.0%	$20.0M+5.3%	$21.6M+20.1%	$17.5M-0.3%	$25.2M+49.3%	$19.0M+11.8%	$18.0M-38.2%	$17.6M-7.4%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Inventory	$530.1M+0.5%	$527.4M-5.0%	$546.3M-5.0%	$558.0M-3.7%	$527.6M-8.5%	$555.4M-1.9%	$575.2M+0.7%	$579.6M-7.0%
Accounts Receivable	N/A	N/A	$386.8M+2.0%	N/A	N/A	N/A	$379.2M+1.0%	N/A
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$181.0M-4.8%	$181.0M-0.6%	$181.0M-0.6%	$190.0M+4.3%	$190.2M+4.4%	$182.2M0.0%	$182.2M0.0%	$182.2M0.0%
Total Liabilities	$1.8B+14.2%	$1.8B+18.3%	$1.9B+17.8%	$1.7B+8.3%	$1.6B+2.0%	$1.6B+1.3%	$1.6B+2.4%	$1.6B-0.3%
Current Liabilities	$693.5M+7.8%	$662.6M+9.0%	$695.2M+5.4%	$701.6M+2.8%	$643.3M-4.1%	$608.0M-4.1%	$659.9M-6.4%	$682.4M-2.9%
Non-Current Liabilities	$1.1B+18.6%	$1.2B+24.2%	$1.2B+26.8%	$984.5M+12.6%	$946.3M+6.6%	$948.6M+5.1%	$917.5M+9.8%	$874.1M+1.8%
Total Equity	$741.8M-4.4%	$739.5M-5.8%	$743.5M-4.5%	$781.3M+0.5%	$776.3M+1.0%	$785.2M+3.4%	$778.2M+1.6%	$777.3M-0.4%
Retained Earnings	$280.1M-14.1%	$281.6M-12.6%	$287.4M-9.4%	$329.6M+4.9%	$326.3M+5.0%	$322.4M+7.9%	$317.1M+7.5%	$314.3M+4.2%

Not reported in any period shown, so not listed: Long-Term Debt.

SPTN Cash Flow Statement

SPTN quarterly cash flow statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	$186.3M	$205.9M+130.5%	$89.3M-19.1%	$110.3M-31.5%	$161.2M-47.5%	$306.7M+70.2%	$180.2M+5.0%	$171.7M+224.8%	$52.8M-66.4%	$157.2M-29.7%	$223.5M+60.7%	$139.1M+134.4%	$59.3M-36.7%	$93.7M+4.4%	$89.8M-2.1%	$91.7M
Depreciation & Amortization	N/A	$103.4M+4.8%	$98.6M+4.7%	$94.2M+1.6%	$92.7M+3.2%	$89.9M+1.7%	$88.4M+6.7%	$82.9M-1.8%	$84.4M+6.6%	$79.2M-6.7%	$84.9M-4.0%	$88.5M+127.7%	$38.9M+5.7%	$36.8M+4.2%	$35.3M+1.1%	$34.9M
Stock-Based Compensation	N/A	$10.7M-13.1%	$12.3M+46.9%	$8.4M+21.6%	$6.9M+9.0%	$6.3M-13.9%	$7.3M-4.4%	$7.6M-20.4%	$9.6M+21.1%	$7.9M+9.6%	$7.2M+4.3%	$6.9M+70.8%	$4.1M-19.5%	$5.0M-6.0%	$5.4M+16.1%	$4.6M
Capital Expenditures	$116.5M	$132.4M+10.0%	$120.3M+23.7%	$97.3M+22.5%	$79.4M+18.0%	$67.3M-10.0%	$74.8M+4.6%	$71.5M+0.8%	$70.9M-3.4%	$73.4M-7.5%	$79.4M-11.8%	$90.0M+114.3%	$42.0M-1.2%	$42.5M+28.7%	$33.0M-34.6%	$50.5M
Free Cash Flow	$69.8M	$73.5Mn/m	-$31.0M-337.2%	$13.1M-84.0%	$81.7M-65.9%	$239.4M+127.2%	$105.4M+5.2%	$100.2Mn/m	-$18.1M-121.6%	$83.8M-41.9%	$144.1M+193.8%	$49.1M+183.1%	$17.3M-66.2%	$51.2M-9.7%	$56.7M+37.6%	$41.2M
Investing Cash Flow	-$227.0M	-$247.0Mn/m	-$116.5Mn/m	-$100.9Mn/m	-$48.0Mn/m	-$57.2Mn/m	-$143.2Mn/m	-$64.2Mn/m	-$315.4Mn/m	-$68.2M-13145.3%	$523K	N/A	-$53.1Mn/m	-$43.8Mn/m	-$33.1Mn/m	-$58.0M
Financing Cash Flow	$40.9M	$44.8M+178.5%	$16.1M+78.2%	$9.0Mn/m	-$122.4Mn/m	-$253.8Mn/m	-$31.2Mn/m	-$104.3M-141.1%	$254.0Mn/m	-$86.6M	N/A	N/A	-$26.2Mn/m	-$67.2Mn/m	-$19.4Mn/m	-$27.9M
Dividends Paid	$30.6M	$29.9M+0.8%	$29.7M-0.2%	$29.7M+4.9%	$28.3M-17.9%	$34.5M+66.6%	$20.7M-20.1%	$25.9M+4.9%	$24.7M+9.8%	$22.5M+10.8%	$20.3M+12.2%	$18.1M+162.2%	$6.9M+16.4%	$5.9M+31.0%	$4.5M+0.9%	$4.5M
Share Buybacks	-$51K	$15.0M-19.0%	$18.5M-43.0%	$32.5M+510.2%	$5.3M-46.8%	$10.0M	N/A	$20.0M-42.8%	$35.0M+288.8%	$9.0M0.0%	$9.0M+80.5%	$5.0M-56.2%	$11.4M-8.1%	$12.4M	N/A	N/A

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Operating Cash Flow	$86.7M-9.3%	$25.8M-29.2%	$82.6Mn/m	-$8.8M-119.2%	$95.6M+82.6%	$36.5Mn/m	-$6.4M-106.2%	$46.0Mn/m
Depreciation & Amortization	$27.9M+19.4%	$36.8M+20.2%	$25.3M+8.0%	$24.2M+4.8%	$23.3M+3.9%	$30.6M+3.0%	$23.4M+6.8%	$23.0M+5.5%
Stock-Based Compensation	N/A	$5.6M+51.7%	N/A	N/A	N/A	$3.7M-27.7%	N/A	N/A
Capital Expenditures	$19.6M-27.2%	$31.6M-21.3%	$34.5M+1.2%	$30.8M+21.3%	$26.9M+22.5%	$40.2M+3.3%	$34.1M+10.1%	$25.4M+27.9%
Free Cash Flow	$67.1M-2.3%	-$5.8Mn/m	$48.1Mn/m	-$39.6M-292.1%	$68.7M+126.0%	-$3.7Mn/m	-$40.5M-156.3%	$20.6Mn/m
Investing Cash Flow	-$22.5Mn/m	-$37.0Mn/m	-$136.4Mn/m	-$31.2Mn/m	-$41.4Mn/m	-$38.1Mn/m	-$34.5Mn/m	-$24.9M-625.1%
Financing Cash Flow	-$58.7Mn/m	$9.5M+260.4%	$57.8M+40.1%	$32.3Mn/m	-$48.0Mn/m	$2.6M-91.1%	$41.3Mn/m	-$20.4M-245.3%
Dividends Paid	$7.7M+1.4%	$8.0M-0.6%	$7.3M-0.1%	$7.6M+1.3%	$7.6M+0.8%	$8.1M+3.4%	$7.3M+0.4%	$7.5M+0.5%
Share Buybacks	$0-100.0%	$0-100.0%	-$51Kn/m	$0n/m	$12.4M+63.3%	$2.6M-76.0%	$0-100.0%	$0-100.0%

SPTN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPTN quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Gross Margin	15.8%+0.6pp	15.3%-0.3pp	15.5%-0.2pp	15.7%+0.5pp	15.2%+0.7pp	14.6%+0.8pp	13.8%-0.6pp	14.4%-0.3pp	14.7%+0.1pp	14.6%0.0pp	14.6%-6.3pp	20.9%-0.2pp	21.1%-0.9pp	22.0%+0.1pp	21.9%
Operating Margin	0.6%-0.5pp	1.1%+0.4pp	0.7%-0.5pp	1.3%+0.2pp	1.1%+0.4pp	0.7%-0.2pp	0.9%+2.2pp	-1.3%-2.8pp	1.4%-0.2pp	1.6%+0.2pp	1.5%-0.9pp	2.3%-0.2pp	2.5%-0.2pp	2.7%+0.4pp	2.3%
Net Margin	0.0%-0.5pp	0.5%+0.2pp	0.4%-0.5pp	0.8%0.0pp	0.8%+0.7pp	0.1%-0.3pp	0.4%+1.1pp	-0.7%-1.4pp	0.8%-0.1pp	0.8%+0.1pp	0.7%-0.3pp	1.1%-0.2pp	1.2%-0.1pp	1.3%+0.3pp	1.0%
Return on Equity	0.0%-6.7pp	6.7%+2.2pp	4.5%-4.9pp	9.4%-0.9pp	10.3%+9.5pp	0.8%-3.9pp	4.7%+12.0pp	-7.3%-14.2pp	6.9%-1.0pp	7.9%+0.1pp	7.8%-0.3pp	8.2%-1.6pp	9.8%-0.8pp	10.6%+1.2pp	9.3%
Return on Assets	0.0%-2.2pp	2.2%+0.7pp	1.5%-1.8pp	3.3%0.0pp	3.3%+3.1pp	0.3%-1.5pp	1.7%+4.3pp	-2.6%-5.5pp	2.9%-0.3pp	3.3%+0.2pp	3.0%-0.4pp	3.5%-0.7pp	4.2%-0.1pp	4.3%	N/A
Current Ratio	1.57-0.1x	1.63+0.1x	1.51+0.1x	1.460.0x	1.47-0.3x	1.76-0.3x	2.10+0.1x	2.03+0.3x	1.770.0x	1.81-0.2x	2.00+0.9x	1.07-0.1x	1.13-0.2x	1.29	N/A
Debt-to-Equity	N/A	N/A	N/A	N/A	0.65-0.3x	0.990.0x	0.95-0.1x	1.03+0.5x	0.50-0.1x	0.59-0.1x	0.74+0.3x	0.430.0x	0.41-0.1x	0.56	N/A
Liabilities-to-Equity	2.50+0.5x	2.030.0x	2.01+0.2x	1.82-0.3x	2.10-0.2x	2.31+0.6x	1.75-0.1x	1.85+0.5x	1.34-0.1x	1.42-0.2x	1.59+0.2x	1.350.0x	1.36-0.1x	1.46	N/A
Asset Turnover	3.67-0.5x	4.13-0.1x	4.18+0.1x	4.05-0.1x	4.10+0.4x	3.75-0.3x	4.09+0.2x	3.870.0x	3.92-0.1x	3.99-0.1x	4.10+0.8x	3.30-0.1x	3.45+0.1x	3.37	N/A
FCF Margin	0.8%+1.1pp	-0.3%-0.5pp	0.1%-0.8pp	0.9%-1.6pp	2.6%+1.3pp	1.2%0.0pp	1.2%+1.5pp	-0.2%-1.3pp	1.1%-0.8pp	1.9%+1.3pp	0.6%0.0pp	0.7%-1.3pp	1.9%-0.3pp	2.2%+0.6pp	1.6%

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Gross Margin	16.9%+1.0pp	16.6%+0.9pp	16.1%+1.0pp	15.8%+0.4pp	15.8%+0.6pp	15.7%+0.3pp	15.1%+0.3pp	15.3%+0.1pp
Operating Margin	0.8%-0.4pp	0.7%-0.4pp	-1.2%-2.3pp	1.1%+0.1pp	1.2%-0.4pp	1.1%+0.3pp	1.1%+0.7pp	1.0%+0.2pp
Net Margin	0.3%-0.2pp	0.1%-0.4pp	-1.6%-2.0pp	0.5%0.0pp	0.5%-0.3pp	0.5%+0.1pp	0.5%+0.4pp	0.5%+0.1pp
Return on Equity	0.8%-0.7pp	0.3%-1.4pp	-4.7%-6.0pp	1.4%0.0pp	1.5%-1.0pp	1.7%+0.2pp	1.3%+1.2pp	1.4%+0.2pp
Return on Assets	0.2%-0.3pp	0.1%-0.5pp	-1.4%-1.8pp	0.4%0.0pp	0.5%-0.3pp	0.5%+0.1pp	0.4%+0.4pp	0.5%+0.1pp
Current Ratio	1.57-0.1x	1.66-0.1x	1.57-0.1x	1.620.0x	1.620.0x	1.75+0.1x	1.63+0.1x	1.590.0x
Liabilities-to-Equity	2.45+0.4x	2.49+0.5x	2.50+0.5x	2.16+0.2x	2.050.0x	1.980.0x	2.030.0x	2.000.0x
Asset Turnover	0.89-0.1x	1.13-0.1x	0.87-0.1x	0.91-0.1x	0.94-0.1x	1.20-0.1x	0.950.0x	0.970.0x
FCF Margin	3.0%-0.1pp	-0.2%-0.1pp	2.1%+3.9pp	-1.8%-2.7pp	3.1%+1.8pp	-0.1%+1.3pp	-1.8%-4.9pp	0.9%+2.7pp

Not reported in any period shown, so not listed: Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
SpartanNash Company SPTN	FY2024	$9.5B	$299K	0.0%	N/A	37/100
Mission Produce, Inc. AVO	FY2025	$1.4B	$37.7M	2.7%	$1.0B	55/100
United Natural Foods Inc UNFI	FY2026	$31.2B	$84.0M	0.3%	$2.9B	31/100
Andersons Inc/The ANDE	FY2025	$11.0B	$95.7M	0.9%	$2.2B	42/100

Where SpartanNash Company Ranks

Frequently Asked Questions

What is SpartanNash Company's annual revenue?

SpartanNash Company (SPTN) reported $9.5B in total revenue for fiscal year 2024. This represents a -1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SpartanNash Company's revenue growing?

SpartanNash Company (SPTN) revenue declined by 1.8% year-over-year, from $9.7B to $9.5B in fiscal year 2024.

Is SpartanNash Company profitable?

No, SpartanNash Company (SPTN) reported a net loss of $15.9M over the trailing 12 months to July 12, 2025. In fiscal year 2024 it reported a net income of $299K, with a net profit margin of 0.0%.

What is SpartanNash Company's EBITDA?

SpartanNash Company (SPTN) had EBITDA of $157.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is SpartanNash Company's gross margin?

SpartanNash Company (SPTN) had a gross margin of 15.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is SpartanNash Company's operating margin?

SpartanNash Company (SPTN) had an operating margin of 0.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is SpartanNash Company's net profit margin?

SpartanNash Company (SPTN) had a net profit margin of 0.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does SpartanNash Company pay dividends?

Yes, SpartanNash Company (SPTN) paid $0.87 per share in dividends during fiscal year 2024.

What is SpartanNash Company's return on equity (ROE)?

SpartanNash Company (SPTN) has a return on equity of 0.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is SpartanNash Company's free cash flow?

SpartanNash Company (SPTN) generated $73.5M in free cash flow during fiscal year 2024. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is SpartanNash Company's operating cash flow?

SpartanNash Company (SPTN) generated $205.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are SpartanNash Company's total assets?

SpartanNash Company (SPTN) had $2.6B in total assets as of fiscal year 2024, including both current and long-term assets.

What are SpartanNash Company's capital expenditures?

SpartanNash Company (SPTN) invested $132.4M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Does SpartanNash Company buy back shares?

Yes, SpartanNash Company (SPTN) spent $15.0M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does SpartanNash Company have outstanding?

SpartanNash Company (SPTN) had 34M shares outstanding as of fiscal year 2024.

What is SpartanNash Company's current ratio?

SpartanNash Company (SPTN) had a current ratio of 1.57 as of fiscal year 2024, which is generally considered healthy.

What is SpartanNash Company's liabilities-to-equity ratio?

SpartanNash Company (SPTN) had a liabilities-to-equity ratio of 2.50 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2024, because the filing data we hold for that year carries no long-term debt figure.

What is SpartanNash Company's return on assets (ROA)?

SpartanNash Company (SPTN) had a return on assets of 0.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is SpartanNash Company's Piotroski F-Score?

SpartanNash Company (SPTN) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are SpartanNash Company's earnings high quality?

SpartanNash Company (SPTN) reported $299K of net income while generating $205.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can SpartanNash Company cover its interest payments?

SpartanNash Company (SPTN) has an interest coverage ratio of 1.20x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is SpartanNash Company?

SpartanNash Company (SPTN) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.